| abstract |
The present invention provides novel active agent (eg, peptides, small organic molecules, amino acid pairs, etc.) peptides that ameliorate one or more symptoms of atherosclerosis and / or other pathologies characterized by an inflammatory response. In certain embodiments, the peptide is similar to the G * amphoteric helix of apolipoprotein J. The active agent is highly stable and easily administered via the oral route. |